Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 2
2015 3
2016 3
2017 2
2018 6
2019 2
2020 4
2021 7
2022 7
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients.
Napolitano D, Settanni CR, Parisio L, Orgiana N, Poscia A, Schiavoni E, Turchini L, Cascio AL, Germini F, Sblendorio E, Milani A, Patteril C, Laterza L, Lopetuso LR, Pugliese D, Papa A, Gasbarrini A, Scaldaferri F. Napolitano D, et al. Among authors: laterza l. Indian J Gastroenterol. 2024 Feb;43(1):215-225. doi: 10.1007/s12664-023-01500-2. Epub 2024 Jan 20. Indian J Gastroenterol. 2024. PMID: 38244138
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission.
Parisio L, Settanni CR, Varca S, Laterza L, Lopetuso LR, Napolitano D, Schiavoni E, Turchini L, Fanali C, Alfieri N, Pizzoferrato M, Papa A, Pafundi PC, Armuzzi A, Gasbarrini A, Pugliese D, Scaldaferri F. Parisio L, et al. Among authors: laterza l. J Gastrointestin Liver Dis. 2023 Dec 22;32(4):452-459. doi: 10.15403/jgld-5084. J Gastrointestin Liver Dis. 2023. PMID: 38147610 Free article.
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study.
Lopetuso LR, Laterza L, Petito V, Pecere S, Quaranta G, Del Chierico F, Puca P, Schiavoni E, Napolitano D, Poscia A, Ianiro G, Pugliese D, Putignani L, Sanguinetti M, Armuzzi A, Masucci L, Gasbarrini A, Cammarota G, Scaldaferri F. Lopetuso LR, et al. Among authors: laterza l. Microorganisms. 2023 Oct 11;11(10):2536. doi: 10.3390/microorganisms11102536. Microorganisms. 2023. PMID: 37894194 Free PMC article.
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19.
Laterza L, Putignani L, Settanni CR, Petito V, Varca S, De Maio F, Macari G, Guarrasi V, Gremese E, Tolusso B, Wlderk G, Pirro MA, Fanali C, Scaldaferri F, Turchini L, Amatucci V, Sanguinetti M, Gasbarrini A. Laterza L, et al. Int J Mol Sci. 2023 Apr 1;24(7):6623. doi: 10.3390/ijms24076623. Int J Mol Sci. 2023. PMID: 37047594 Free PMC article.
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights.
Marano G, Mazza M, Lisci FM, Ciliberto M, Traversi G, Kotzalidis GD, De Berardis D, Laterza L, Sani G, Gasbarrini A, Gaetani E. Marano G, et al. Among authors: laterza l. Nutrients. 2023 Mar 20;15(6):1496. doi: 10.3390/nu15061496. Nutrients. 2023. PMID: 36986226 Free PMC article. Review.
45 results